PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Lis, K.* ; Plewka, J.* ; Cardoso Micu Menezes, F.M. ; Bielecka, E.* ; Chykunova, Y.* ; Pustelny, K.* ; Niebling, S.* ; Garcia, A.S.* ; Garcia-Alai, M.* ; Popowicz, G.M. ; Czarna, A.* ; Kantyka, T.* ; Pyrc, K.*

SARS-CoV-2 Mpro oligomerization as a potential target for therapy.

Int. J. Biol. Macromol. 267:131392 (2024)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
The main protease (Mpro) of SARS-CoV-2 is critical in the virus's replication cycle, facilitating the maturation of polyproteins into functional units. Due to its conservation across taxa, Mpro is a promising target for broad-spectrum antiviral drugs. Targeting Mpro with small molecule inhibitors, such as nirmatrelvir combined with ritonavir (Paxlovid™), which the FDA has approved for post-exposure treatment and prophylaxis, can effectively interrupt the replication process of the virus. A key aspect of Mpro's function is its ability to form a functional dimer. However, the mechanics of dimerization and its influence on proteolytic activity remain less understood. In this study, we utilized biochemical, structural, and molecular modelling approaches to explore Mpro dimerization. We evaluated critical residues, specifically Arg4 and Arg298, that are essential for dimerization. Our results show that changes in the oligomerization state of Mpro directly affect its enzymatic activity and dimerization propensity. We discovered a synergistic relationship influencing dimer formation, involving both intra- and intermolecular interactions. These findings highlight the potential for developing allosteric inhibitors targeting Mpro, offering promising new directions for therapeutic strategies.
Impact Factor
Scopus SNIP
Altmetric
7.700
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Dimerization ; M(pro) ; Sars-cov-2; Respiratory Syndrome Coronavirus; 3c-like Protease; Main Protease; Dimerization; Catalysis; Dimer; Visualization; Mechanism; Efficient; Reveals
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 0141-8130
e-ISSN 1879-0003
Zeitschrift International Journal of Biological Macromolecules
Quellenangaben Band: 267, Heft: , Seiten: , Artikelnummer: 131392 Supplement: ,
Verlag Elsevier
Verlagsort Radarweg 29, 1043 Nx Amsterdam, Netherlands
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Structural Biology (STB)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503000-001
Förderungen National Science Center
Innovative Medicines Initiative two Joint Undertaking (JU)
DURABLE project
European Union
National Science Centre
NAWA Polish Returns 2018
Foundation for Polish Science

Polish Ministry of Science and Higher Education
DOI 10.1016/j.ijbiomac.2024.131392
WOS ID 001242446400001
Scopus ID 85189941073
PubMed ID 38582483
Erfassungsdatum 2024-05-24
[➜Korrektur melden]